Robbins LLP Reminds Brainstorm Cell Therapeutics Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Against BCLI Brainstorm Cell Therapeutics Inc. (BCLI) Misled Investors About the Viability and Efficacy of its drug NurOwn